M. Ezekowitz
Circulation · 2001–2019
A researcher in the Science corpus: 25 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Papers from M. Ezekowitz's perspective
Ordered by how strongly the researchers M. Ezekowitz trusts endorse each paper. Same corpus, a different order for every researcher.
- Newly identified events in the RE-LY trial. (New England Journal of Medicine)
- New ideas about atrial fibrillation 50 years on (Nature)
- HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm… (Heart Rhythm)
- Detection and Quantification of Left Atrial Structural Remodeling Using Delayed Enhancement MRI in Patients with Atrial Fibrillation (Circulation)
- The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. (Journal of the American College of Cardiology)
- Atrio-Esophageal Fistula as a Complication of Percutaneous Transcatheter Ablation of Atrial Fibrillation (Circulation)
- Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation. (Journal of the American College of Cardiology)
- Recovered Pulmonary Vein Conduction as a Dominant Factor for Recurrent Atrial Tachyarrhythmias After Complete Circular Isolation of the Pulmonary Veins: Lessons From Double Lasso Technique (Circulation)
- Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up? (Journal of the American College of Cardiology)
- The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. (New England Journal of Medicine)
Their papers
- 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation. (2019) — 1,222 citations
- 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. (2019) — 1,772 citations
- 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. (2019) — 1,752 citations
- The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy). (2014) — 863 citations
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. (2014) — 4,384 citations
- 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation (2014) — 4,453 citations
- 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. (2014) — 1,866 citations
- 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. (2014) — 709 citations
- 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. (2014) — 688 citations
- Edoxaban versus warfarin in patients with atrial fibrillation. (2013) — 4,723 citations
- 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. (2012) — 733 citations
- 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design (2012) — 1,949 citations
- 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2011) — 1,012 citations
- 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2011) — 597 citations
- Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation: An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial (2011) — 1,187 citations
- 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the Europe (2011) — 871 citations
- Forecasting the Future of Cardiovascular Disease in the United States: A Policy Statement From the American Heart Association (2011) — 2,972 citations
- 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. (2011) — 1,867 citations
- Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial. (2010) — 997 citations
- Newly identified events in the RE-LY trial. (2010) — 733 citations